ANBIPING
Anbiping is a number of reagents and supporting devices have indeed been independently created by Anbiping, which focuses on tumour screening and correct diagnosis. Pathology is the main application department. It has been established that product lines for liquid-based cytology, polymerase chain reaction, immunohistochemistry, and fluorescence in situ hybridization can be used to screen for and diagnose tumors based on everything from cell morphology to protein expression.
ANBIPING
Social Links:
Industry:
Biopharma Biotechnology Health Care Health Diagnostics Manufacturing Medical Pharmaceutical
Founded:
2005-07-06
Status:
Active
Contact:
020-32299997
Email Addresses:
[email protected]
Total Funding:
63 M CNY
Technology used in webpage:
IPhone / Mobile Compatible Viewport Meta Euro SPF Mobile Non Scaleable Content HSTS Apache Pound Sterling Apple Mobile Web App Capable Japanese Yen
Similar Organizations
Arctic Therapeutics
Arctic Therapeutics (AT) uses bioinformatic approaches and AI to eliminate major risks associated with traditional drug development.
Aro Biotherapeutics
Aro Biotherapeutics develops tissue-targeted genetic medicines using Centyrins, a proprietary technology, to address complex diseases.
Bioblue Technology
Bioblue Technology focuses on the research and development of early tumor diagnosis products.
Biosino Bio-Technology & Science
Biosino Bio-Technology & Science is engaged in research and development of invitro diagnostics reagent products.
Instadiagnostics
Instadiagnostics Inc., is developing a rapid, quantitative, point-of-care (POC) diagnostic platform.
Halo Labs
Halo Labs is a biotechnology company that specializes in analytical instrumentation and biopharma.
Yestar Healthcare Holdings
Yestar Healthcare Holdings supplies medical consumables and equipment like medical imaging products and vitro diagnostic products.
Current Employees Featured
Founder
Stock Details
Investors List
ShenZhen GTJA Investment Group
ShenZhen GTJA Investment Group investment in Series C - Anbiping
Qushui Aiwei
Qushui Aiwei investment in Series C - Anbiping
Xinguodu
Xinguodu investment in Series B - Anbiping
Jinshi Investment
Jinshi Investment investment in Series B - Anbiping
Weishi Touzi
Weishi Touzi investment in Series B - Anbiping
Ganjing Touzi
Ganjing Touzi investment in Series A - Anbiping
Sinopharm Capital
Sinopharm Capital investment in Series A - Anbiping
Daan Jiyin
Daan Jiyin investment in Series A - Anbiping
CDF-Capital
CDF-Capital investment in Series A - Anbiping
ZD Capital
ZD Capital investment in Angel Round - Anbiping
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2023-10-24 | Fangxin Medical Technology | Anbiping investment in Corporate Round - Fangxin Medical Technology | 10 M CNY |
| 2022-09-23 | ThunderBio Innovation | Anbiping investment in Venture Round - ThunderBio Innovation | N/A |
| 2022-07-15 | Gaugene | Anbiping investment in Series B - Gaugene | 100 M CNY |
| 2022-05-19 | Targene Medical | Anbiping investment in Venture Round - Targene Medical | N/A |
More informations about "Anbiping"
Anbiping - Crunchbase Investor Profile & Investments
Anbiping is a number of reagents and supporting devices have indeed been independently created by Anbiping, which focuses on tumour screening and …See details»
Home-LBP SYSTEM
Home-Guangzhou Anbiping Medical Science and Technology Co. , Ltd. (stock code: 688393) focuses on tumor screening and diagnosis, independently developed a series of tumor …See details»
广州安必平医药科技股份有限公司-肿瘤-筛查与诊断-LBP-PCR-IHC-…
广州安必平医药科技股份有限公司（股票代码：688393）专注于肿瘤筛查与诊断，自主研发了一系列肿瘤筛查及诊断试剂与配套设备，主要应用科室为病理科。目前已搭建液基细胞学（lbp） …See details»
Anbiping (Shaanxi) Pharmaceutical Technology Co., Ltd.
Feb 22, 2025 Explore Anbiping (Shaanxi) Pharmaceutical Technology Co., Ltd. with its drug pipeline, therapeutic area, technology platform, .See details»
安必平医学检验
广州安必平医学检验（简称“安必平医检”）是国内病理诊断领域首家上市企业——广州安必平医药科技股份有限公司（股票代码：688393）的控股子公司。安必平医检致力于让各级医疗机构 …See details»
Guangzhou Anbiping Automated Testing Equipment Co., Ltd
Find company research, competitor information, contact details & financial data for Guangzhou Anbiping Automated Testing Equipment Co., Ltd of Guangzhou, Guangdong. Get the latest …See details»
广州安必平医药科技股份有限公司
安必平成立于2005年，2020年8月20日在上交所科创板成功上市，是国内病理诊断领域首家上市公司。 公司专注于肿瘤筛查与精准诊断，自主研发了一系列试剂与配套设备，主要应用科室为 …See details»
Anbiping | Company | RadialReport
Anbiping focuses on R&D, production, and service of pathological diagnostic products. Technology: Others Industry: Deep DiagnosticsSee details»
Anbiping - Investments, Portfolio & Company Exits - Crunchbase
Anbiping focuses on R&D, production, and service of pathological diagnostic products. New. Resources. Advanced Search. Start Free Trial . Talk With Sales. Pricing. Log In. Log In. …See details»
Guangzhou Lbp Medicine Science & Technology Co., Ltd. (China)
May 16, 2025 Anbiping (Guangzhou) Marketing Management Co., Ltd. 100%. Company Performance. Financial values in the chart are available after Guangzhou Lbp Medicine …See details»
Guangzhou Anbiping Medical Laboratory Co., Ltd.: Drug pipelines ...
Jul 2, 2023 Explore Guangzhou Anbiping Medical Laboratory Co., Ltd. with its drug pipeline, therapeutic area, technology platform, .See details»
安必平医检 - 安必平医学检验 - accupath.cn
广州安必平医学检验（简称“安必平医检”）是国内病理诊断领域首家上市企业——广州安必平医药科技股份有限公司（股票代码：688393）的控股子公司。安必平医检致力于让各级医疗机构 …See details»
广州安必平医药科技股份有限公司 - 顺企网
Sep 5, 2022 这里是广州安必平医药科技股份有限公司在顺企网广州黄页的介绍页，位于广州高新技术产业开发区南翔三路11号自编7栋，营业范围有医学研究和试验发展;生物技术转让服务; …See details»
Anbiping - Crunchbase
Anbiping focuses on R&D, production, and service of pathological diagnostic products.See details»
广州安必平医药科技股份有限公司 - 百度百科
广州安必平医药科技有限公司是一家集细胞学诊断、免疫组织化学诊断及分子诊断等病理诊断系列产品的研发、生产、销售以及技术指导与服务为一体的、高速发展的生物医药高新技术企业。 …See details»
Hangzhou Anbiping Pharmaceutical Technology Co., Ltd.
Explore Hangzhou Anbiping Pharmaceutical Technology Co., Ltd. with its drug pipeline, therapeutic area, technology platform, .See details»
Anbiping: it is proposed to increase the capital of anbiping …
Cailian, September 23 (Xinhua) -- anbiping announced that the company plans to make a joint contribution of RMB 20 million to Guangzhou anbiping medical laboratory Co., Ltd. ("anbiping …See details»
Anbiping - Funding, Financials, Valuation & Investors - Crunchbase
Anbiping is registered under the ticker SSE:688393 . Their stock opened with CN¥30.56 in its Aug 20, 2020 IPO. Anbiping is funded by 11 investors. ShenZhen GTJA Investment Group and …See details»
技术平台 - 安必平医学检验
广州安必平医学检验（简称“安必平医检”）是国内病理诊断领域首家上市企业——广州安必平医药科技股份有限公司（股票代码：688393）的控股子公司。安必平医检致力于让各级医疗机构 …See details»
Anbiping - Contacts, Employees, Board Members, Advisors & Alumni
Anbiping focuses on R&D, production, and service of pathological diagnostic products. New. Resources. Advanced Search. Start Free Trial . Talk With Sales. Pricing. Log In. Log In. …See details»